Daily news email for March 29, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Cellmid Launches Évolis (TM) Hair Products

LingVitae, Plarion and KTH Royal Institute of Technology Initiate a Collaboration to Provide ...

Vetter Experts Speak at Pharma Congress 2012

Definiens Expands Stereology Capabilities for Quantitative Digital Pathology

Ceva Takes Commercial License for ProBioGen's AGE1.CR Cell Line for Viral Vaccine Production

Nile Therapeutics, Inc. Announces Positive Clinical Trial Results Evaluating the Subcutaneous Infusion of Cenderitide

Build New Drugs "On Demand" With Bacteria, Cornell University Study

Genta Incorporated Completes Financing of Up to $12 Million

Mylan Inc. Also Interested in Actavis, as Watson Pharmaceuticals, Inc. Moves Closer to Deal: Report

In Cancer Science, Many "Discoveries" Don't Hold Up, Amgen Reveals

BioSpace - Breaking News
e-Therapeutics plc' Phase I Clinical Trials of Cancer Drug ETS2101 Approved by Regulators

Hubei Minkang Pharmaceutical Ltd. Signs a MOU With Hubei Merryclin Pharmaceuticals

Forest Laboratories, Inc. and Almiralll Announce FDA has Extended the Review Period for Aclidinium Bromide

KYNAMRO (mipomersen sodium) Data Presented at

Horizon Pharma, Inc. Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R)

Biotech News - Business Wire
Computerworld Recognizes Dell for Support of Childhood Cancer Research

DaniMer Scientific and Myriant Announce Strategic Alliance to Develop Eco-Friendly, Cost-Effective Bio-Materials

Iams Celebrates Senior Pets with Estelle Harris and Launch of Iams Senior Plus

Oticon, Inc. Introduces Invisible Hearing Device For People Who Want the Ultimate in Discretion

Courtagen Introduces Genomic Profiling Services in their Newly Licensed CLIA Lab

Biotech News - PR Newswire
US Lab Deployed to Boost Mexico's Response to Outbreaks of Infectious Disease

One Year Data Provide Evidence of Effectiveness and Tolerability of REPLAGAL® (agalsidase alfa) in Fabry Patients

Lineagen Presents Data Showing Clinical Utilization of FirstStepDx®, a New Model of Genetic Service Delivery, at the 2012 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

BioMarCare Receives Strategic Investment From Micromedic Ltd., a Subsidiary of BioLight Ltd.

Oncothyreon Prices $47.0 Million Public Offering of Common Stock

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
The April 2012 Issue of The Burrill Report

Roche and Illumina Duke It out Ahead of Annual Meeting

Groups Seek Congressional Action on Drug Shortages

JNJ Faces Flood of Lawsuits for Unauthorized Medical Device

MediVector Lands $138.5 Million Defense Contract

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Five Oral Presentations on Clinical Experience With NanoKnife® System Featured at Society of Interventional Radiology Conference

Avita Medical Initiates Trading on US OTCQX

Study Establishes Safety and Clinical Benefit of SIR-Spheres® microspheres in Treating Metastatic Liver Tumors in Patients who Failed Systemic Chemotherapy

NeuroScience, Inc. Introduces Teevance and Selevance to Address Health Issues Associated with Autonomic Imbalances

Indiana University Health Researchers Present Data on RF Surgical Technology at 59th AORN Congress

Clinical Trials - PR Newswire
MarginProbe® System zeigt nennenswerten Rückgang von notwendigen Folgeoperationen bei Brustkrebspatienten sowie Kosteneffektivität

Studie findet, dass die Wiederherstellung des Sinusrhythmus, die Herzfunktion von Patienten mit anhaltendem Vorhofflimmern verbessern kann

Une étude suggère que le rétablissement du rythme sinusal est susceptible d'améliorer la fonction cardiaque des patients atteints de fibrillation auriculaire persistante

MarginProbe® System Shows Substantial Reduction in Need for Repeat Surgeries for Breast Cancer Patients and Cost Effectiveness

Universität Maryland führt bislang umfassendste Gesichtstransplantation durch

CNN Top Stories
CDC: Autism cases in U.S. kids up 78% in decade

No U.S. access to Afghan killing sites

No U.S. access to Afghan killing sites, official says

Will court let health care law stand

Syrians wary as leaders plan to meet

Contract Pharma
ProImmune Launches Custom Assay Service

Quintiles, Archimedes Partner for Simulation Model

Halo To Acquire Teva's Mirabel Facility

Almac, Affymetrix In Global Xcel Array Distribution Pact

BioSeek Extends Merck Serono Pact

FDA Drugs- What's New
FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses

Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA News - Business Wire
Genzyme and Isis Announce Submission of U.S. NDA for KYNAMRO (mipomersen sodium) in Homozygous Familial Hypercholesterolemia

Tau Therapeutics LLC to Present Posters at AACR on T-Type Calcium Channel Inhibitors and Interlaced Therapy

Forest Laboratories and Almirall Announce FDA has Extended the Review Period for Aclidinium Bromide

EpiCept to Raise $1.1 Million in Registered Direct Offering

Smiths Medical Issues a Market Withdrawal for CoZmonitor Blood Glucose Monitoring Systems

FDA Press Releases
FDA pursues enforcement action against California fish processor

FDA to discuss risks and benefits of metal-on-metal hip replacements

FDA approves additional blood test for viruses linked to leukemia, neurologic diseases

FDA approves Omontys to treat anemia in adult patients on dialysis

New FDA guidance on considerations used in device approval, de novo decisions

FDA Vaccines, Blood and Biologics - What's New
WinRho SDF Liquid

Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Is an Amylin takeover inevitable after the BMS rejection

VC boom: U.K. charity births $80M biotech fund for cancer drug research

FDA rejects Chelsea's Northera, demands additional study data

Merrimack Pharma discounts expectations in $100M IPO

Moscow backs clones of Western biotech programs in Russia

FierceBiotech IT
Tech startup drills into social media noise for drug and device outfits

Computer-based discovery biotech from Israel lands in Bay Area

Big Pharma and devicemakers plot careful social media moves

Dr. Atul Butte - Fierce's Top 10 Biotech Techies

Samir Brahmachari - Fierce's Top 10 Biotech Techies

FierceBiotech Research
Researchers coax immature brain stem cells from connective tissue

Protein deficiency a tantalizing key to type 2 diabetes

NEJM: Blame chronic diarrhea on mutated gene

Infant trauma, genetics combine to boost schizophrenia odds

The Vatican cancels stem cell conference

Allergan asks FDA for lucrative new Botox indication

Who's next to move on Amylin Analysts say Big Pharma looms

Vytorin outcomes study barrels on without a peek

Bloomberg: Watson on verge of deal for Actavis

Amylin reportedly stiff-armed $3.5B offer from BMS

FiercePharma Manufacturing
Sandoz Canada president explains shortages to House of Commons

Halo agrees to buy Teva's Montreal facility

Novartis plant disruptions affect pet treatments

CMC, third-party manufacturing issues delay Map drug launch

California implant makers get FDA warnings

Study: No benefit for Merck's zoster booster

Gardasil could cut cancer in women already infected with HPV

Genetic tweaking could create chlamydia vaccine

Narcolepsy spike linked with flu shot

Academics' oral stomach flu vax could save lives

Health News - BizJournals.com
FDA requests additional drug trial for Chelsea Therapeutics Northera

GenSpera preparing anti-cancer drug compound for Phase II study

Bovie profits on increased demand, new products

What does health care reform mean for California

CareFirst reserves debate in D.C. will play out in different environment

Health News - CNBC
Authorities charge JetBlue pilot for midair meltdown

Applied Materials CEO on Health Care

High Court Weighs Health Law

Authorities charges JetBlue pilot for midair meltdown

Fate of Obama Care in Supreme Court's Hands

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Illumina Advises Stockholders to Defer Taking Any Action in Response to Roche's Increased Offer

Roche Ups Bid for Illumina to $51 Per Share, or $6.5B

House Joins Senate in Passing JOBS Act, Promising Relief for Biopharma Startups

Goldman Sachs Points to Possible Three-Phase Breakup of Pfizer Businesses

AB SCIEX Announces Academic Partnership Program to Support Biological Research

Marketwire - Pharma and Biotech
ZYTO Corp Chairman and CEO to Provide Business Update

CNS Response Appoints Maurice J. DeWald to Board of Directors

Critical Outcome Technologies Inc. Reports Fiscal 2012 Third Quarter Financial Results

The American Academy of Facial Plastic and Reconstructive Surgery Leadership Demonstrates Popular Anti-Aging Procedures in New York City

BioSyent Releases Fiscal 2011 and Fourth Quarter Financial Results-Strong Growth Continues

MassBio News
Norton High School Named MassBioEd Innovative School of the Year

Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

Medical Pharma - PR Newswire
Does CyberKnife® Radiosurgery for Prostate Cancer Add Up

CVS Caremark to Highlight Commitment to Older Americans at American Society on Aging Conference

New Addition to Family of Mobile Biofeedback Apps with 20 Million Users -- Sleep Time by Azumio -- Now Available for iPhone

The Leukemia & Lymphoma Society Launches 22nd Annual Man & Woman of the Year Campaign to Fight Blood Cancer

Mouthing Off Against Oral Cancer

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

New York Times- Pharmaceuticals
The Place to Head Off Malaria

Judge Bars Imported Drugs in Executions

Amgen Loses Monopoly on Drug for Dialysis Patients

Drug to Cut Cholesterol Level Tests Better Than Statins

The Case for Sleep Medicine

1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

Comparator sourcing is a complex challenge in a globalised market says Clinigen

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

European CMO market will double in just 6 years, says Frost & Sullivan

Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

Pharma News - Business Wire
Research and Markets: 2012 Epidemiology Report: Alzheimer's Disease - Differential Aging between Genders will Dramatically Impact Prevalent Cases

Boston Medical Center Joins Blue Cross Blue Shield of Massachusetts Alternative Quality Contract

Clearside Biomedical Announces Addition of Highly Seasoned Executive to Its Board of Directors

PharmCode by Vybion for Precision in Target Validation

Dementia Patients Still Facing a Postcode Lottery on Treatment, Says Stephen McPartland MP

Pharma News - PharmiWeb
Surgeon General Releases New Report on Youth Smoking

Frost & Sullivan: U.S. Nuclear Medicine and PET Imaging Systems Market Witnessed a Rebound in 2010, With PET Blazing the Trail

Almac and Affymetrix Announce a Global Distribution Agreement

Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market

Blue Cross Foundation Announces $500,000 Grant

Pharma News - PR Newswire
Public Interest Groups, Leading Competition Advocates Call On State Attorneys General to Block ESI/Medco Merger

Drugstore Lobby Wants New Collective Bargaining Powers

Talyst Partners with Medacist Solutions Group to Provide Comprehensive Reporting

ICSE Pharma Outsourcing Event Announces Conference Agenda for US Debut in May

Onyx Pharmaceuticals Announces Cell Publication Demonstrating Selectivity of Immunoproteasome Inhibitor ONX 0914

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
DIA and FDA Join Together to Open Dialogue on Current and Emerging...

Oak Ridge National Laboratory to Partner with Knowledge Foundation for...

Graduate Students Earn $15,000 Awards for Innovative Solutions to Pet...

SynCardia Total Artificial Heart Patient at University of Washington...

Rasheda Ali is a Force to be reckoned with in the Fight Against...

PRWeb - Pharmaceuticals
Australia's Max Relief Launches in US

Growing Consumer Concerns about Health and Well-being Continue to...

Mental Health Information Site, HealthyPlace, Builds Awareness Through...

World Spices and Seasonings Market to Reach 5.3 Billion lbs (Pounds)...

MD247 Unveils Telemedicine Option for Vacationers

Scientific American
Ancient Human Had Feet Like an Ape

Coloring-Book Pages Transformed into 3D Animations via New Software

Primeval Precipitation: What Fossil Imprints of Rain Reveal about Early Earth

New Maps of Mercury Show Icy Looking Craters on the Solar System's Innermost Planet

Pupfish, Downfish: Subterranean Tsunami Gives Vertical Shakes to the Water-Hole Home of Endangered Fishes

Sports - ESPN Basketball
Stan Van Gundy: UK beating Wizards 'absurd'

Mich. St. AD regrets tweet to Michigan's Burke

Mercer hangs on at Utah State to win CIT final

Drew receives extension, staying at Valparaiso

Sources: Ohio's Groce agrees to coach Illinois

Sports News - ESPN
Source: UGA starters Rambo, Ogletree banned

Love out, Patterson in as ASU athletic director

Cincinnati moves home games back to campus

Ex-Terrapins QB O'Brien transfers to Wisconsin

Ex-Spur Robinson's son commits to ND football

Xconomy Life Sciences
Roche Raises Illumina Takeover Bid to $51/Share

Oncothyreon Grabs $47M in Stock Offering

LiquidGrids Re-Launches Social Media Analytics for Health Industry

MAP Pharmaceuticals Gets Rare Benefit of the Doubt With Migraine Drug

Third Rock's Mark Levin: Ultra-Super Positive on Biotech Innovation

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)